Henry Schein (NASDAQ:HSIC) Shares Break Above Fifty Day Moving Average – Here’s What Happened

Shares of Henry Schein, Inc. (NASDAQ:HSIC) passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $86.49 and traded as high as $87.28. Henry Schein shares last traded at $86.62, with a volume of 2,501,802 shares trading hands.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HSIC. UBS Group set a $94.00 price target on Henry Schein and gave the stock a “neutral” rating in a report on Wednesday, August 5th. Piper Sandler upped their price target on Henry Schein from $91.00 to $95.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. BTIG Research upped their target price on Henry Schein from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Barclays reissued an “overweight” rating and set a $100.00 price target (up from $86.00) on shares of Henry Schein in a report on Thursday, August 6th. Finally, BMO Capital Markets started coverage on Henry Schein in a research note on Wednesday, July 8th. They set a “market perform” rating and a $85.00 price target on the stock. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $93.27.

Henry Schein Price Performance

The company has a market cap of $9.65 billion, a PE ratio of 25.25, a price-to-earnings-growth ratio of 1.53 and a beta of 0.84. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.32 and a quick ratio of 0.73. The stock has a fifty day moving average price of $86.49 and a 200-day moving average price of $81.15.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.03. The business had revenue of $3.46 billion for the quarter, compared to analyst estimates of $3.37 billion. Henry Schein had a net margin of 2.96% and a return on equity of 15.97%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.10 EPS. On average, equities analysts expect that Henry Schein, Inc. will post 5.36 earnings per share for the current year.

Institutional Trading of Henry Schein

A number of institutional investors have recently made changes to their positions in HSIC. Fifth Third Wealth Advisors LLC bought a new position in Henry Schein in the third quarter worth approximately $235,000. Root Financial Partners LLC purchased a new stake in Henry Schein in the 3rd quarter worth $50,000. Nisa Investment Advisors LLC grew its holdings in shares of Henry Schein by 1.6% during the third quarter. Nisa Investment Advisors LLC now owns 33,512 shares of the company’s stock worth $2,814,000 after buying an additional 538 shares in the last quarter. USA Financial Formulas acquired a new position in Henry Schein during the third quarter worth $462,000. Finally, V Square Quantitative Management LLC increased its stake in Henry Schein by 18.0% during the third quarter. V Square Quantitative Management LLC now owns 4,026 shares of the company’s stock worth $338,000 after acquiring an additional 614 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc (NASDAQ: HSIC) is a global provider of healthcare products and services serving dental and medical professionals, as well as veterinary practices and laboratories. The company distributes consumable supplies, equipment, pharmaceuticals, vaccines, and other products used in clinical and practice-management settings.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support clinical workflows, electronic health records, practice management, procurement, equipment installation, and technical support.